India Diabetes Devices Market

India Diabetes Devices Market by Management Devices [Disposable Pens, Insulin Cartridges, Insulin Pumps (Indian Pump Reservoir, Infusion Set, and Insulin Pump Device), and Insulin Syringes], Monitoring Devices [Continuous Glucose Monitoring (Durables and Sensors) and Self-monitoring Blood Glucose (Test Strips, Lancets, and Glucometer Devices)], and Geography –Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1020
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 180
  • Format:
  • Pub. Date: Upcoming
  • Share:

The India diabetes devices market size was valued at USD 0.8 million in 2019 and is expected to expand at significant CAGR during the forecast period, 2021 – 2028. Growth of the market is attributed to the increasing funding from government and private organization, rising number of development and research activities, rise in technological advancement, and unhealthy lifestyle.

India Diabetes Devices Market Key Takeaways

The diabetes devices contain disposable pens, insulin cartridges, insulin pumps, and insulin syringes. Each of these devices used by diabetes patients on the basis of their diabetes type and amount of medicine and insulin requirement. The continuous glucose monitoring and self-monitoring blood glucose devices are used to monitor the blood glucose level and to adjust the insulin doses of diabetes patients.

 The Covid-19 pandemic affected the demand and supply of India diabetes devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

  • Rapid urbanization and increasing diabetes population is projected to boost the market in the coming years.
  • Rising prevalence of obesity due to changing life style among people is the major factor fueling the market.
  • Emerging economies and lack of health infrastructure is anticipated to restrict the market growth.
  • Lack of awareness about diabetes devices present a main challenge that can hamper the market expansion during the forecast period.
  • R&D investment and technological advancement in diabetes devices market is projected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the India diabetes devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Diabetes Devices Market – India Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018-2019

Forecast Period

2021-2028

Segmentation

Management Devices [Disposable Pens, Insulin Cartridges, Insulin Pumps (Indian Pump Reservoir, Infusion Set, and Insulin Pump Device), and Insulin Syringes], Monitoring Devices [Continuous Glucose Monitoring (Durables and Sensors) and Self-monitoring Blood Glucose (Test Strips, Lancets, and Glucometer Devices)]

Country

India

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Abbott India Limited, Roche Diagnostics India Pvt Ltd, Indian Medtronic Pvt Ltd, Becton Dickinson Private Limited, Dexcom Inc., BD, Novo Nordisk A/S, Sanofi, Bayer Corporation, Dr Morpean, Bio-Rad Laboratories India Pvt Ltd, Pulsatom Healthcare Pvt Ltd, B Braun Medical India Pvt Ltd., and ARKRAY Healthcare Pvt Ltd.


Market Segment Insights

The self-monitoring blood glucose segment accounts for key share of the market and expected to grow at a rapid pace
Based on monitoring devices, the India diabetes devices market is bifurcated into continuous glucose monitoring and self-monitoring blood glucose. The continuous glucose monitoring segment is sub-segmented into durables and sensors. The self-monitoring segment is sub-segmented into test strips, lancets, and glucometer devices. The self-monitoring blood glucose segment accounts for a key share of the market. Growth of the market is attributed to the increasing funding from government and private organization, rising number of development and research activities, rise in technological advancement, and unhealthy lifestyle. The continuous glucose monitoring segment is anticipated to expand at a rapid pace during the forecast period due to rapid urbanization, increasing diabetes population, rising prevalence of obesity, and increasing adaptation of insulin pumps.

The disposable pen segment is anticipated to expand at a rapid pace during the forecast period
On the basis of management devices, the market of India diabetes devices is categorized into disposable pens, insulin cartridges, insulin pumps, and insulin syringes. The insulin pump segment is sub-segmented into Indian pump reservoir, infusion set, and insulin pump device. The pens come in form of two categorize reusable and disposable. A disposable insulin pen has a cartridge, when the cartridge is over the entire pen is thrown away. An insulin pump is a device which delivers insulin by the pump wearer instruction and automatically. It provides insulin to body through day and delivers large dose of insulin whenever required. The pen needles and insulin syringes are generally used for providing prescribed dose of insulin to the patient’s body. Since the introduction of diabetes medication, the insulin needles are used for providing insulin. Growth of the market is attributed to increasing number of programs started by different health organizations, increasing funding from government and private organization, and rise in technological innovations.

India Diabetes Devices Market By Management Devices

Geographical outlook
The India diabetes devices market is anticipated to expand at a high CAGR during the forecast period due to increase in demand for diabetes care devices and rising awareness about health. Growth of the market is attributed to introduction of technological and novel advanced product and smart insulin pump for self-diabetes management.

Rapid development in the health sector increased the demand for insulin pumps in India. Increasing number of diabetes disease due to change in life style among people is the major factor fueling the market.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Diabetes Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Diabetes Devices Market - Supply Chain
  4.5. Global Diabetes Devices Market Forecast
     4.5.1. Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Diabetes Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Diabetes Devices Market Absolute $ Opportunity
5. Global Diabetes Devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Diabetes Devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Diabetes Devices Demand Share Forecast, 2019-2026
6. North America Diabetes Devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Diabetes Devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Diabetes Devices Demand Share Forecast, 2019-2026
7. Latin America Diabetes Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Diabetes Devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Diabetes Devices Demand Share Forecast, 2019-2026
8. Europe Diabetes Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Diabetes Devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Diabetes Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Diabetes Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Diabetes Devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Diabetes Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Diabetes Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Diabetes Devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Diabetes Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Diabetes Devices Market: Market Share Analysis
  11.2. Diabetes Devices Distributors and Customers
  11.3. Diabetes Devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Abbott India Limited
     11.4.2. Roche Diagnostics India Pvt Ltd
     11.4.3. Indian Medtronic Pvt Ltd
     11.4.4. Becton Dickinson Private Limited
     11.4.5. Dexcom Inc.
Segments Covered in the Report
The India diabetes devices market has been segmented on the basis of

Management Devices
  • Disposable Pens
  • Insulin Cartridges
  • Insulin Pumps
    • Indian Pump Reservoir
    • Infusion Set
    • Insulin Pump Device
  • Insulin Syringes
Monitoring Devices
  • Continuous Glucose Monitoring
    • Durables
    • Sensors
  • Self-monitoring Blood Glucose
    • Test Strips
    • Lancets
    • Glucometer Devices
Geography
  • India
Key Players
  • Abbott India Limited
  • Roche Diagnostics India Pvt Ltd
  • Indian Medtronic Pvt Ltd
  • Becton Dickinson Private Limited
  • Dexcom Inc.
  • BD
  • Novo Nordisk A/S
  • Sanofi
  • Bayer Corporation
  • Dr Morpean
  • Bio-Rad Laboratories India Pvt Ltd
  • Pulsatom Healthcare Pvt Ltd
  • B Braun Medical India Pvt Ltd.
  • ARKRAY Healthcare Pvt Ltd.

Key players competing in the India diabetes devices market include Abbott India Limited, Roche Diagnostics India Pvt Ltd, Indian Medtronic Pvt Ltd, Becton Dickinson Private Limited, Dexcom Inc., BD, Novo Nordisk A/S, Sanofi, Bayer Corporation, Dr Morpean, Bio-Rad Laboratories India Pvt Ltd, Pulsatom Healthcare Pvt Ltd, B Braun Medical India Pvt Ltd., and ARKRAY Healthcare Pvt Ltd.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and rise their production line of the business in the coming years.

 India Diabetes Devices Market By Key Players

Buy Report